Trabectedin-related rhabdomyolysis: an uncommon but fatal toxicity

Tumori. 2011 Mar-Apr;97(2):252-5. doi: 10.1177/030089161109700223.

Abstract

Rhabdomyolysis is defined as the dissolution of striped muscle characterized by the leakage of intracellular muscle components into the circulation, which can ultimately lead to renal failure with a possible fatal outcome. Trabectedin is a potential cause of rhabdomyolysis. Herein, we describe a case of rhabdomyolysis in a female patient with recurrent metastatic leiomyosarcoma of the uterus and who had full recovery, and we review the already published cases in order to identify a common pattern of emergence.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Agents, Alkylating / adverse effects*
  • Biomarkers / blood
  • Comorbidity
  • Creatine Kinase / blood*
  • Dioxoles / administration & dosage
  • Dioxoles / adverse effects*
  • Drug Interactions
  • Fatal Outcome
  • Female
  • Humans
  • Leiomyosarcoma / drug therapy*
  • Leiomyosarcoma / enzymology
  • Leiomyosarcoma / secondary
  • Renal Insufficiency / etiology
  • Rhabdomyolysis / chemically induced*
  • Rhabdomyolysis / complications
  • Rhabdomyolysis / enzymology
  • Tetrahydroisoquinolines / administration & dosage
  • Tetrahydroisoquinolines / adverse effects*
  • Trabectedin
  • Uterine Neoplasms / drug therapy*
  • Uterine Neoplasms / enzymology
  • Uterine Neoplasms / pathology

Substances

  • Antineoplastic Agents, Alkylating
  • Biomarkers
  • Dioxoles
  • Tetrahydroisoquinolines
  • Creatine Kinase
  • Trabectedin